Prevention for the older woman: A practical guide to prevention and treatment of osteoporosis

Geriatrics

Volumn 57, Issue 4, 2002, Pages 16-27

  Messinger Rapport, Barbara J ^a   Thacker, Holly L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; FEMHRT; MEDROXYPROGESTERONE ACETATE; PARATHYROID HORMONE; PIPERAZINE ESTRONE SULFATE; PROGESTERONE; RALOXIFENE; RISEDRONIC ACID; SALCATONIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; VITAMIN D;

AGED; BODY WEIGHT; CASE REPORT; DENSITOMETRY; DIET; ETHNOLOGY; EXERCISE; FAMILY HISTORY; FEMALE; FRACTURE; HUMAN; OSTEOPOROSIS; POSTMENOPAUSE; REVIEW; RISK FACTOR;

AGED; AGED, 80 AND OVER; CALCITONIN; DENSITOMETRY, X-RAY; DIPHOSPHONATES; ESTROGEN REPLACEMENT THERAPY; EXERCISE; FEMALE; FRACTURES, BONE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTORS; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 0036211659     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. The worldwide problem of osteoporosis. Insights afforded by epidemiology
2. Prevention for the older woman, part 1: A practical guide to assessing physical and cognitive function
3. Prevention for the older woman, part 2: A practical guide to hormone replacement therapy and urogynecologic health
4. Bone mass, rates of osteoporotic fractures, and prevention of fractures: Are there differences between China and western countries?
5. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group
6. Osteoporosis and its management in older women
7. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women
8. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol
9. A prospective study of alcohol consumption and bone mineral density
10. HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients
11. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells
12. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women
13. Use of statins and risk of fractures
14. Effect of two randomised exercise programmes on bone mass of healthy postmenopausal women
15. Physical exercise as prophylaxis, against involutional vertebral bone loss: A controlled trial
16. Additive effects of weight-bearing exercise and estrogen on bone mineral density in older women
17. Vertebral bone loss: An unheeded side effect of therapeutic bed rest
18. Epidemiology and predictors of fractures associated with osteoporosis
19. Estrogen treatment of patients with established postmenopausal osteoporosis
20. The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women
21. Treatment of postmenopausal osteoporosis with transdermal estrogen
22. Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group
23. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
24. Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures
25. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial
26. Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis
27. Alendronate in early postmenopausal women: Effects on bone mass during long-term treatment and after withdrawal
28. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial
29. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women
30. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmeno-pausal women: A randomized, controlled trial
31. Drug therapy: Treatment of postmenopausal osteoporosis
32. Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women
33. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis